Twitter and Urology
Stacy Loeb, MD, MSc, assistant professor, Department of Urology, Population Health, New York University, at the 2014 AUA Annual Meeting, discusses how urologists can use Twitter.
At the 2014 AUA Annual Meeting, Stacy Loeb, MD, MSc, assistant professor, Department of Urology, Population Health, New York University, discusses how urologists can use Twitter.
#AUA14is underway! We're just sitting down with@LoebStacyfor an interview now. We'll have some highlights ...
TargetedOnc (@TargetedOnc)May 16, 2014
Loeb: Urologists who don't use Twitter are missing out on an important research and networking tool.#AUA14
TargetedOnc (@TargetedOnc)May 16, 2014
Novel Frontline Treatments Add Layer of Complexity in Urothelial Carcinoma
January 2nd 2025The past 12 months have seen the FDA approvals of enfortumab vedotin plus pembrolizumab for patients with locally advanced or metastatic urothelial cancer and nivolumab plus cisplatin and gemcitabine for patients with unresectable or metastatic urothelial carcinoma.
Read More
Could Triapine With Lutetium 177 Dotatate Improve Outcomes for Neuroendocrine Tumors?
December 30th 2024Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with lutetium 177 dotatate for treating well-differentiated somatostatin receptor–-positive neuroendocrine tumors.
Read More
